A carregar...
Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
BACKGROUND AND AIM: It is unclear how adding an anti‐tumor necrosis factor alpha agent to immunomodulator (IM) treatment, as a step‐up strategy, affects long‐term outcomes in ulcerative colitis. This retrospective study investigated persistence associated with biologic anti‐tumor necrosis factor alp...
Na minha lista:
| Publicado no: | J Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7027773/ https://ncbi.nlm.nih.gov/pubmed/31397010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.14825 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|